Vesugen 20mg (Bioregulator)

$65.00

Vesugen 20mg is the synthetic Khavinson short-peptide bioregulator derived from vascular-endothelial tissue fractions, for in-vitro vascular-cell and angiogenesis research. Greater than 99 percent HPLC verified.

Peptide Science research editorial team.

Vesugen 20mg (Bioregulator) Overview

Vesugen 20mg from Peptide Science is the synthetic Khavinson short-peptide bioregulator derived from vascular-endothelial tissue fractions, supplied as a lyophilised vial for in-vitro and preclinical vascular-cell research. Vesugen is one of the most-cited cardiovascular-targeted members of the Khavinson family in published research literature.

Khavinson Short-Peptide Class Background

Vesugen 20mg (Bioregulator) belongs to the Khavinson short-peptide family, a class of synthetic two-to-four-residue peptides originally derived from bioregulator-fraction extracts of mammalian tissues by V. Kh. Khavinson and colleagues from the 1980s onward. The class is characterised by short sequence length (typically 2 to 4 amino acids), organ-specific source-tissue derivation, and synthetic reconstitution of the original tissue-fraction activity. The full class includes Epithalon (pineal), Cortexin (cerebral cortex), Pinealon (pineal), Vesugen (vascular), and the dozen organ-specific bioregulators in this catalogue.

Vascular Bioregulator Research Context

Vesugen is studied in preclinical research for vascular-endothelial cell signalling pathways and angiogenesis-pathway models. The compound is paired with Cardiogen in cardiovascular-system research protocols where vascular and cardiac-muscle bioregulator effects are studied side by side. Browse the broader bioregulator peptide range for related Khavinson short peptides.

Vial Specifications

Vesugen 20mg (Bioregulator) research specifications
Property Value
Compound Vesugen 20mg (Bioregulator)
Class Khavinson short-peptide bioregulator
Source-tissue derivation Vascular-endothelial tissue fraction
Supplied form Lyophilised powder, sealed vial
Strength 20 mg per vial
Purity greater than 99 percent (HPLC verified)
Storage 2 to 8 degrees Celsius lyophilised; minus 20 degrees Celsius long-term

For paired research with the cardiac-muscle bioregulator, see Cardiogen 20mg. For the related vascular bioregulator, see Vesilute 20mg.

Reconstitution and Handling

The lyophilised short peptide reconstitutes with bacteriostatic water at the working concentration set by the principal investigator. Aliquoting reconstituted stock for single-use frozen storage is the standard handling practice cited in Khavinson-tradition research protocols.

Quality and Shipping

Each batch passes HPLC at greater than 99 percent purity, with mass-spectrometry identity confirmation. A Certificate of Analysis accompanies every order. Material is filled in a US laboratory under ISO 9001:2015-aligned quality systems and dispatched in temperature-monitored insulated packaging via overnight or two-day courier.

For laboratory research and development use only. Not for human or veterinary consumption. Has not been evaluated by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Purchasers acknowledge they are qualified researchers age 21 or older and accept responsibility for compliance with all applicable federal, state, and local laws. Lyophilised vials store at 2 to 8 degrees Celsius; protect from light.

Reviews

There are no reviews yet.

Be the first to review “Vesugen 20mg (Bioregulator)”

Your email address will not be published. Required fields are marked *

Scroll to Top